{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:53:53Z","timestamp":1786758833824,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s40271-019-00384-9","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T04:16:36Z","timestamp":1566965796000},"page":"83-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers"],"prefix":"10.1007","volume":"13","author":[{"given":"Rebecca","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Sully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Doward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verna","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Peloquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Gater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"384_CR1","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6:e441.","journal-title":"Blood Cancer J."},{"key":"384_CR2","first-page":"398","volume":"17","author":"L Finn","year":"2017","unstructured":"Finn L, Dalovisio A, Foran J. Older patients with acute myeloid leukemia: treatment challenges and future directions. Ochsner J. 2017;17:398\u2013404.","journal-title":"Ochsner J."},{"key":"384_CR3","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1016\/j.clml.2018.05.003","volume":"18","author":"JA Bell","year":"2018","unstructured":"Bell JA, Galaznik A, Huelin R, Stokes M, Guo Y, Fram RJ, et al. Effectiveness and safety of therapeutic regimens for elderly patients with acute myeloid leukemia: a systematic literature review. Clin Lymphoma Myeloma Leuk. 2018;18:e303\u201314.","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"384_CR4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","volume":"29","author":"A Burnett","year":"2011","unstructured":"Burnett A, Wetzler M, L\u00f6wenberg B. Therapeutic advances in acute myeloid leukemia. J Clin Oncol. 2011;29:487\u201394.","journal-title":"J Clin Oncol."},{"key":"384_CR5","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1038\/bcj.2016.3","volume":"6","author":"H Bower","year":"2016","unstructured":"Bower H, Andersson TM, Bj\u00f6rkholm M, Dickman PW, Lambert PC, Derolf AR. Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer J. 2016;6:e390.","journal-title":"Blood Cancer J."},{"key":"384_CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2407-9-252","volume":"9","author":"F Bhayat","year":"2009","unstructured":"Bhayat F, Das-Gupta E, Smith C, McKeever T, Hubbard R. The incidence of and mortality from leukaemias in the UK: a general population-based study. BMC Cancer. 2009;9:252.","journal-title":"BMC Cancer."},{"key":"384_CR7","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","volume":"113","author":"G Juliusson","year":"2009","unstructured":"Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113:4179\u201387.","journal-title":"Blood."},{"key":"384_CR8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3324\/haematol.2010.026252","volume":"96","author":"M Maynadi\u00e9","year":"2011","unstructured":"Maynadi\u00e9 M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d\u2019Or (Burgundy, France). Haematologica. 2011;96:55\u201361.","journal-title":"Haematologica."},{"key":"384_CR9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12185-012-1146-2","volume":"96","author":"T Matsunaga","year":"2012","unstructured":"Matsunaga T, Yamashita K, Kubuki Y, Toyama T, Imataki O, Maeda K, et al. Acute myeloid leukemia in clinical practice: a retrospective population-based cohort study in Miyazaki Prefecture, Japan. Int J Hematol. 2012;96:342\u20139.","journal-title":"Int J Hematol."},{"key":"384_CR10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/0284186X.2014.889851","volume":"53","author":"BK Shah","year":"2014","unstructured":"Shah BK, Ghimire KB. Improved survival among older acute myeloid leukemia patients: a population-based study. Acta Oncol. 2014;53:935\u20138.","journal-title":"Acta Oncol."},{"key":"384_CR11","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/10428194.2014.947610","volume":"56","author":"G Osca-Gelis","year":"2015","unstructured":"Osca-Gelis G, Puig-Vives M, Saez M, Gallardo D, Lloveras N, Guardia R, et al. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study. Leuk Lymphoma. 2015;56:896\u2013902.","journal-title":"Leuk Lymphoma."},{"key":"384_CR12","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/cncr.28129","volume":"119","author":"MS Thein","year":"2013","unstructured":"Thein MS, Ershler WB, Jemal A, Yates JW, Baer MR. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer. 2013;119:2720\u20137.","journal-title":"Cancer."},{"key":"384_CR13","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3324\/haematol.2012.066100","volume":"97","author":"B Oran","year":"2012","unstructured":"Oran B, Weisdorf DJ. Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica. 2012;97:1916\u201324.","journal-title":"Haematologica."},{"key":"384_CR14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.leukres.2008.12.008","volume":"33","author":"T Yogaparan","year":"2009","unstructured":"Yogaparan T, Panju A, Minden M, Brandwein J, Mohamedali HZ, Alibhai SM. Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia. Leuk Res. 2009;33:1288\u201390.","journal-title":"Leuk Res."},{"key":"384_CR15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jgo.2015.04.002","volume":"6","author":"SM Alibhai","year":"2015","unstructured":"Alibhai SM, Breunis H, Timilshina N, Brignardello-Petersen R, Tomlinson G, Mohamedali H, et al. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J Geriatr Oncol. 2015;6:262\u201371.","journal-title":"J Geriatr Oncol."},{"key":"384_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40487-016-0039-6","volume":"5","author":"EE Korol","year":"2017","unstructured":"Korol EE, Wang S, Johnston K, Ravandi-Kashani F, Levis M, van Nooten F. Health-related quality of life of patients with acute myeloid leukemia: a systematic literature review. Oncol Ther. 2017;5:1\u201316.","journal-title":"Oncol Ther."},{"key":"384_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1534735417699881","volume":"17","author":"AL Bryant","year":"2018","unstructured":"Bryant AL, Deal AM, Battaglini CL, Phillips B, Pergolotti M, Coffman E, et al. The effects of exercise on patient-reported outcomes and performance-based physical function in adults with acute leukemia undergoing induction therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL). Integr Cancer Ther. 2018;17:263\u201370.","journal-title":"Integr Cancer Ther."},{"key":"384_CR18","doi-asserted-by":"crossref","first-page":"A160","DOI":"10.1016\/j.jval.2016.03.1483","volume":"19","author":"F van Nooten","year":"2016","unstructured":"van Nooten F, Korol EE, Levis M, Ravandi-Kashani F, Wang S, Johnston K. Health-related quality of life of patients with acute myeloid leukemia: a systematic literature review. Value Health. 2016;19:A160.","journal-title":"Value Health."},{"key":"384_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/CEOR.S187409","volume":"11","author":"A Forsythe","year":"2019","unstructured":"Forsythe A, Kwon CS, Bell T, Smith TA, Arondekar B. Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature review. Clinicoecon Outcomes Res. 2019;11:87\u201398.","journal-title":"Clinicoecon Outcomes Res."},{"key":"384_CR20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11136-017-1581-x","volume":"27","author":"L Forsythe","year":"2018","unstructured":"Forsythe L, Heckert A, Margolis MK, Schrandt S, Frank L. Methods and impact of engagement in research, from theory to practice and back again: early findings from the Patient-Centered Outcomes Research Institute. Qual Life Res. 2018;27:17\u201331.","journal-title":"Qual Life Res."},{"key":"384_CR21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585530-000000000-00000","volume":"4","author":"M Baldwin","year":"2011","unstructured":"Baldwin M, Spong A, Doward L, Gnanasakthy A. Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond. Patient. 2011;4:11\u20137.","journal-title":"Patient."},{"key":"384_CR22","unstructured":"US Food and Drug Administration. Patient-focused drug development: collecting comprehensive and representative input. Guidance for industry, Food and Drug Administration staff, and other stakeholders. Draft guidance. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM610442.pdf . Accessed 20 Aug 2019."},{"key":"384_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-018-1247-8","volume":"17","author":"L McDonald","year":"2019","unstructured":"McDonald L, Malcolm B, Ramagopalan S, Syrad H. Real-world data and the patient perspective: the PROmise of social media? BMC Med. 2019;17:11.","journal-title":"BMC Med."},{"key":"384_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2014.10.001","volume":"18","author":"M Rothman","year":"2015","unstructured":"Rothman M, Gnanaskathy A, Wicks P, Papadopoulos EJ. Can we use social media to support content validity of patient-reported outcome instruments in medical product development? Value Health. 2015;18:1\u20134.","journal-title":"Value Health."},{"key":"384_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jval.2015.10.013","volume":"19","author":"KP McCarrier","year":"2016","unstructured":"McCarrier KP, Bull S, Fleming S, Simacek K, Wicks P, Cella D, et al. Concept elicitation within patient-powered research networks: a feasibility study in chronic lymphocytic leukemia. Value Health. 2016;19:42\u201352.","journal-title":"Value Health."},{"key":"384_CR26","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.2196\/ijmr.2669","volume":"2","author":"HM Chen","year":"2013","unstructured":"Chen HM, Hu ZK, Zheng XL, Yuan ZS, Xu ZB, Yuan LQ, et al. Effectiveness of YouTube as a source of medical information on heart transplantation. Interact J Med Res. 2013;2:e28.","journal-title":"Interact J Med Res."},{"key":"384_CR27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jvsv.2016.10.078","volume":"5","author":"TM Kwok","year":"2017","unstructured":"Kwok TM, Singla AA, Phang K, Lau AY. YouTube as a source of patient information for varicose vein treatment options. J Vasc Surg Venous Lymphat Disord. 2017;5:238\u201343.","journal-title":"J Vasc Surg Venous Lymphat Disord."},{"key":"384_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/clc.21981","volume":"35","author":"S Pant","year":"2012","unstructured":"Pant S, Deshmukh A, Murugiah K, Kumar G, Sachdeva R, Mehta JL. Assessing the credibility of the \u201cYouTube approach\u201d to health information on acute myocardial infarction. Clin Cardiol. 2012;35:281\u20135.","journal-title":"Clin Cardiol."},{"key":"384_CR29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.urology.2008.07.059","volume":"75","author":"PL Steinberg","year":"2010","unstructured":"Steinberg PL, Wason S, Stern JM, Deters L, Kowal B, Seigne J. YouTube as source of prostate cancer information. Urology. 2010;75:619\u201322.","journal-title":"Urology."},{"key":"384_CR30","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.2196\/ijmr.8612","volume":"6","author":"W Tang","year":"2017","unstructured":"Tang W, Olscamp K, Choi SK, Friedman DB. Alzheimer\u2019s disease in social media: content analysis of YouTube videos. Interact J Med Res. 2017;6:e19.","journal-title":"Interact J Med Res."},{"key":"384_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40271-017-0215-2","volume":"10","author":"JL Lee","year":"2017","unstructured":"Lee JL, Frey M, Frey P, Hollin IL, Wu AW. Seeing is engaging: vlogs as a tool for patient engagement. Patient. 2017;10:267\u201370.","journal-title":"Patient."},{"key":"384_CR32","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/PPA.S151752","volume":"12","author":"JF Bridges","year":"2018","unstructured":"Bridges JF, Oakes AH, Reinhart CA, Voyard E, O\u2019Donoghue B. Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia. Patient Prefer Adherence. 2018;12:647\u201355.","journal-title":"Patient Prefer Adherence."},{"key":"384_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpainsymman.2017.09.014","volume":"55","author":"NA Boucher","year":"2018","unstructured":"Boucher NA, Johnson KS, LeBlanc TW. Acute leukemia patients\u2019 needs: qualitative findings and opportunities for early palliative care. J Pain Symptom Manag. 2018;55:433\u20139.","journal-title":"J Pain Symptom Manag."},{"key":"384_CR34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/bjd.13583","volume":"172","author":"LE Selman","year":"2015","unstructured":"Selman LE, Beynon T, Radcliffe E, Whittaker S, Orlowska D, Child F, et al. \u2018We\u2019re all carrying a burden that we\u2019re not sharing\u2019: a qualitative study of the impact of cutaneous T-cell lymphoma on the family. Br J Dermatol. 2015;172:1581\u201392.","journal-title":"Br J Dermatol."},{"key":"384_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/15524256.2012.758608","volume":"9","author":"P McGrath","year":"2013","unstructured":"McGrath P. End-of-life care in hematology: update from Australia. J Soc Work End Life Palliat Care. 2013;9:96\u2013110.","journal-title":"J Soc Work End Life Palliat Care."},{"key":"384_CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1478951506060470","volume":"4","author":"JF Dahan","year":"2006","unstructured":"Dahan JF, Auerbach CF. A qualitative study of the trauma and posttraumatic growth of multiple myeloma patients treated with peripheral blood stem cell transplant. Palliat Support Care. 2006;4:365\u201387.","journal-title":"Palliat Support Care."},{"key":"384_CR37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.leukres.2018.02.009","volume":"67","author":"AL Deckert","year":"2018","unstructured":"Deckert AL, Gheihman G, Nissim R, Chung C, Schimmer AD, Zimmermann C, et al. The importance of meaningful activity in people living with acute myeloid leukemia. Leuk Res. 2018;67:86\u201391.","journal-title":"Leuk Res."},{"key":"384_CR38","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s00520-014-2230-3","volume":"22","author":"R Nissim","year":"2014","unstructured":"Nissim R, Rodin G, Schimmer A, Minden M, Rydall A, Yuen D, et al. Finding new bearings: a qualitative study on the transition from inpatient to ambulatory care of patients with acute myeloid leukemia. Support Care Cancer. 2014;22:2435\u201343.","journal-title":"Support Care Cancer."},{"key":"384_CR39","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/pon.648","volume":"12","author":"MC Xuereb","year":"2003","unstructured":"Xuereb MC, Dunlop R. The experience of leukaemia and bone marrow transplant: searching for meaning and agency. Psychooncology. 2003;12:397\u2013409.","journal-title":"Psychooncology."},{"key":"384_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2354.2010.01234.x","volume":"20","author":"K Maher","year":"2011","unstructured":"Maher K, de Vries K. An exploration of the lived experiences of individuals with relapsed multiple myeloma. Eur J Cancer Care (Engl). 2011;20:267\u201375.","journal-title":"Eur J Cancer Care (Engl)."},{"key":"384_CR41","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/07347332.2016.1221017","volume":"34","author":"SM Hannum","year":"2016","unstructured":"Hannum SM, Clegg Smith K, Coa K, Klassen AC. Identity reconstruction among older cancer survivors: age and meaning in the context of a life-altering illness. J Psychosoc Oncol. 2016;34:477\u201392.","journal-title":"J Psychosoc Oncol."},{"key":"384_CR42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ptj\/80.5.459","volume":"80","author":"KM Mackey","year":"2000","unstructured":"Mackey KM, Sparling JW. Experiences of older women with cancer receiving hospice care: significance for physical therapy. Phys Ther. 2000;80:459\u201368.","journal-title":"Phys Ther."},{"key":"384_CR43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00520-009-0793-1","volume":"19","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis A, Wilson B, Blair S, Howe T, Cavet J. Living with multiple myeloma: experiences of patients and their informal caregivers. Support Care Cancer. 2011;19:101\u201311.","journal-title":"Support Care Cancer."},{"key":"384_CR44","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1300\/J077v26n02_07","volume":"26","author":"J Puterman","year":"2008","unstructured":"Puterman J, Cadell S. Timing is everything: the experience of parental cancer for young adult daughters: a pilot study. J Psychosoc Oncol. 2008;26:103\u201321.","journal-title":"J Psychosoc Oncol."},{"key":"384_CR45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/JNR.0000000000000088","volume":"23","author":"Z Farsi","year":"2015","unstructured":"Farsi Z. The meaning of disease and spiritual responses to stressors in adults with acute leukemia undergoing hematopoietic stem cell transplantation. J Nurs Res. 2015;23:290\u20137.","journal-title":"J Nurs Res."},{"key":"384_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3928\/19404921-20101201-03","volume":"4","author":"MH Crighton","year":"2011","unstructured":"Crighton MH, Lingler JH, Happ MB. Fit and misfit. Res Gerontol Nurs. 2011;4:27\u201335.","journal-title":"Fit and misfit. Res Gerontol Nurs."},{"key":"384_CR47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmjspcare-2016-001289","volume":"8","author":"D McCaughan","year":"2018","unstructured":"McCaughan D, Roman E, Smith AG, Garry A, Johnson M, Patmore R, et al. Determinants of hospital death in haematological cancers: findings from a qualitative study. BMJ Support Palliat Care. 2018;8:78\u201386.","journal-title":"BMJ Support Palliat Care."},{"key":"384_CR48","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1182\/blood.V126.23.2119.2119","volume":"126","author":"TW LeBlanc","year":"2015","unstructured":"LeBlanc TW, Fish LJ, Bloom CT, El-Jawahri A, Davis DM, Locke SC, et al. Patient experiences of acute myeloid leukemia (AML): a qualitative study about diagnosis, illness understanding, and treatment decision-making. Blood. 2015;126:2119.","journal-title":"Blood."},{"key":"384_CR49","first-page":"22","volume":"8","author":"P McGrath","year":"2001","unstructured":"McGrath P. Dying in the curative system: the haematology\/oncology dilemma. Part 1. Aust J Holist Nurs. 2001;8:22\u201330.","journal-title":"Aust J Holist Nurs."},{"key":"384_CR50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1071\/AH14147","volume":"39","author":"P McGrath","year":"2015","unstructured":"McGrath P. Overcoming the distance barrier in relation to treatment for haematology patients: Queensland findings. Aust Health Rev. 2015;39:344\u201350.","journal-title":"Aust Health Rev."},{"key":"384_CR51","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.leu.2403289","volume":"18","author":"MA Sekeres","year":"2004","unstructured":"Sekeres MA, Stone RM, Zahrieh D, Neuberg D, Morrison V, De Angelo DJ, et al. Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia. 2004;18:809\u201316.","journal-title":"Leukemia."},{"key":"384_CR52","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1080\/03007995.2018.1456414","volume":"34","author":"J Seo","year":"2018","unstructured":"Seo J, Smith BD, Estey E, Voyard E, O\u2019Donoghue B, Bridges JFP. Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development. Curr Med Res Opin. 2018;34:2031\u20139.","journal-title":"Curr Med Res Opin."},{"key":"384_CR53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cncr.30982","volume":"124","author":"SA Buckley","year":"2018","unstructured":"Buckley SA, Jimenez-Sahagun D, Othus M, Walter RB, Lee SJ. Quality of life from the perspective of the patient with acute myeloid leukemia. Cancer. 2018;124:145\u201352.","journal-title":"Cancer."},{"key":"384_CR54","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/pon.4309","volume":"26","author":"TW LeBlanc","year":"2017","unstructured":"LeBlanc TW, Fish LJ, Bloom CT, El-Jawahri A, Davis DM, Locke SC, et al. Patient experiences of acute myeloid leukemia: a qualitative study about diagnosis, illness understanding, and treatment decision-making. Psychooncology. 2017;26:2063\u20138.","journal-title":"Psychooncology."},{"key":"384_CR55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jama.2012.29","volume":"307","author":"M Bevans","year":"2012","unstructured":"Bevans M, Sternberg EM. Caregiving burden, stress, and health effects among family caregivers of adult cancer patients. JAMA. 2012;307:398\u2013403.","journal-title":"JAMA."},{"key":"384_CR56","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.16447","volume":"179","author":"D Orlowska","year":"2018","unstructured":"Orlowska D, Selman LE, Beynon T, Radcliffe E, Whittaker S, Child F, Harding R. \u2018It\u2019s a traumatic illness, traumatic to witness\u2019: a qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma. Br J Dermatol. 2018;179:882\u20138.","journal-title":"Br J Dermatol."},{"key":"384_CR57","unstructured":"Cran F, Poynton C, Harness M. Quality of life in patients over 60 with acute myeloid leukaemia on palliative care pathways. In: 49th Annual scientific meeting of the British Society for Haematology; Brighton (UK). Br J Haematol. 2009;145(Suppl. S1): abstract no. 100."},{"key":"384_CR58","unstructured":"Canadian Agency for Drugs and Technologies in Health. pan-Canadian Oncology Drug Review: final clinical guidance report. https:\/\/www.cadth.ca\/sites\/default\/files\/pcodr\/pcodr_midostaurin_rydapt_all_fn_cgr.pdf . Accessed 20 Aug 2019."},{"key":"384_CR59","first-page":"125","volume":"23","author":"AP Brogan","year":"2017","unstructured":"Brogan AP, DeMuro C, Barrett AM, D\u2019Alessio D, Bal V, Hogue SL. Payer perspectives on patient-reported outcomes in health care decision making: oncology examples. J Manag Care Spec Pharm. 2017;23:125\u201334.","journal-title":"J Manag Care Spec Pharm."},{"key":"384_CR60","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jval.2016.04.017","volume":"19","author":"PP Yu","year":"2016","unstructured":"Yu PP. Challenges in measuring cost and value in oncology: making it personal. Value Health. 2016;19:520\u20134.","journal-title":"Value Health."},{"key":"384_CR61","unstructured":"EVIDEM. Evidence and values: impact of decision making. https:\/\/www.evidem.org\/wp\/wp-content\/uploads\/2017\/09\/EVIDEM-10th-Edition-Concept-and-definitions.pdf . Accessed 20 Aug 2019."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-019-00384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40271-019-00384-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-019-00384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T17:24:37Z","timestamp":1664213077000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40271-019-00384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s40271-019-00384-9","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"28 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"These analyses were sponsored by Pfizer Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Rebecca Crawford, Rebecca Conroy, and Lynda Doward are employees of RTI Health Solutions, which received funding from Pfizer Inc. for these analyses. Timothy Bell, Verna Welch, and Francois Peloquin are employees of Pfizer Inc. Chloe Johnson, Kate Sully, and Adam Gater are employees of Adelphi Values, which received funding from Pfizer Inc. for these analyses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Prior to data collection, an institutional review board committee reviewed the YouTube study and determined that the social media review did not constitute research with human subjects. Ethics approval was deemed unnecessary as the study data were located within the public domain. Ethics approval was not required for the literature review study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The datasets generated from YouTube and targeted literature review resources and analyzed for the current study are available from the corresponding author on reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}